Gregory J. Riely, MD, PhD
Posted: Monday, April 15, 2019
Leora Horn, MD, of Vanderbilt University, discusses the challenges of combining tyrosine kinase inhibitors with immunotherapy for lung cancer.
JNCCN Spotlights
View More
Resources
For your Patients